Download presentation
Presentation is loading. Please wait.
Published byReginald Lindsey Modified over 9 years ago
1
1 Pleural Diseases n Pleural effusion n Pneumothorax By : John J. Beneck PA-C, MSPA “Is that supposed to be in there?”
2
2 Case 1 72 year old female with history of heart failure presents with DOE. Recently stopped her evening furosemide because she was “sick of going to the bathroom all night”.
3
3 Case 2 52 Year old male who presents with slowly worsening DOE, vague CP, and weight loss. Hx reveals long term occupation as auto mechanic specializing in brake work.
4
4 Case 3 19 year old male awakened with vague right chest pain, worse with inspiration. Steadily worsening throughout the day. Now severe (9/10) and short of breath.
5
5 Objectives n Definition/types/classifications n Epidemiology n Presentation n Etiology/pathology n Diagnosis/Studies n Interventions/Therapeutics
6
6 Abbreviations n Abx - Antibiotics n AFB – Acid fast Bacilli n BPD – Brochopulmonary Dysplagia n Bx - Biopsy n CF – Cystic Fibrosis n COPD – Chronic Obstructive Pulmonary Disease n CXR – Chest X ray n CP – Costophrenic n DOE – Dyspnea on exertion n DDx – Differential diagnosis n Dz – Disease n HA - Headache n LDH – Lactate dehydrogenase n PMN – Polymorphonucleocyte n Tx – Treatment
7
7 Pleural Effusion n Excessive pleural fluid –Fluid in the space between the lung and the chest wall.
8
UpToDate: April 20098 Pleural Effusion - Epidemiology n Can result from over 50 Pleuropulmonary or systemic disorders Source is NOT evident following diagnostic thoracentesis in up to 25 percent of patients Source is NOT evident following diagnostic thoracentesis in up to 25 percent of patients
9
9 Normal Pleural Fluid n 20ml/day produced n <10ml present at any one time n 1-1.5 Grams/100ml protein n Few mononuclear cells
10
10 Effusion Presentation n Typically Associated with underlying Dz –Dyspnea –Chest pain –Hypoxemia –CXR n Blunt CP angle, forms meniscus n Lateral Decubitus film
11
11 Exam n Decreased Expansion (> 750 ml) n Decreased Fremitus (> 750 ml) n Dull/flat percussion n Decreased Breath sounds n Egophony n Mediastinal shift (>1500 ml)
12
UpToDate 200912 Pleural Effusion Imaging
13
Merckmedicus 200813 Large Effusion
14
UpToDate 200914 Left Pleural Effusion Notice the arc
15
UpToDate 200915 Loculated Pleural Effusion
16
UpToDate 200916 CT Evidence of Effusion
17
17 Diagnosis – Etiology is Key –Most pleural effusions require further evaluation unless their origin is clear (e.g., heart failure, ascites) and the patient is responding well to therapy
18
18 Pleural Effusion Etiology n Why does fluid accumulate? –Abnormal production –Leaking or discharge –Abnormal absorption n Narrowing the DDx –History –Effusion sampling/analysis
19
19 Dx Starts With Classification n Types –Transudative –Exudative
20
20 Pleural Effusion n Transudative pleural effusions n Transudative pleural effusions –Formed when the normal hydrostatic or oncotic pressures are disturbed. n Increased mean capillary pressure (heart failure) n Decreased capillary oncotic pressure (cirrhosis or nephrotic syndrome)
21
21 Pleural Effusion n Exudative pleural effusions –Occur when there is damage or disruption of the normal pleural membranes or vasculature n Increased capillary permeability (Inflamation, neoplasm) n Decreased lymphatic drainage (e.g., tumor involvement of the pleural space, infection, inflammatory conditions, or trauma)
22
22 Exudative Effusion (cont.) –Chylothorax –Pulmonary emboli –Parapneumonic –Malignancy –Drug or radiation reactions
23
23 Exudates – Light’s Criteria n Exudates have at least one (and transudates NONE) of the following: –(Pleural fluid : serum) protein ratio more than 0.5 –(Pleural fluid : serum) lactate dehydrogenase (LDH) ratio more than 0.6 –Pleural fluid LDH more than two-thirds of the upper limit of normal for serum LDH
24
24 Gross Analysis of Pleural Fluid n Blood –Pulmonary infarction –Tumor –Trauma –(Pleural fluid : blood) hematocrit ratio more than 0.5 establishes the diagnosis of a Hemothorax n Odor n Color n Viscosity
25
25 Lab Analysis of Pleural Fluid n pH n Glucose n LDH n Amylase n Triglycerides
26
26 Other Studies n Cell count and differential n Protein n Microbiologic stains –Wright’s –Gram –AFB –Fungal n Cultures n Cytology
27
27 Now… about these studies…
28
28 pH Less Than 7.3 n Empyema n Tuberculosis n Malignancy n Connective tissue disease n Esophageal rupture
29
29 Glucose Concentration Less Than 40 mg/dl n Empyema n Tuberculosis n Malignancy n Connective tissue disease
30
30 Elevation of Amylase n Pancreatitis n Pancreatic pseudocyst n Malignancy n Esophageal rupture n Pancreatic n Salivary
31
31 Elevation of Triglycerides (>110 mg/dl) n Chylous effusions –Thoracic duct rupture from trauma, surgery, or malignancy (usually lymphoma) n Chyliform effusions
32
32 Last Resort for Diagnosis n Closed Pleural Biopsy –Exudative pleural effusion indeterminate by thoracentesis
33
33 Pleural Effusion Treatment -General- n Variable depending on effusion type and symptomatology –To drain, or not to drain
34
34 Symptomatic Pleural Effusions n May require removal of large amounts of pleural fluid n Rapid removal of > 1 liter of fluid may rarely result in ipsilateral pulmonary edema
35
35 2 Specific Exudative Effusions n Parapneumonic effusions n Malignant effusions
36
36 Parapneumonic Effusions n Associated with bacterial pneumonia n Exudates with a leukocyte count usually more than 10,000/mm 3 and a predominance of PMNs n Thoracentesis is required to identify pathogen(s)
37
37 Parapneumonic Effusions (cont.) n Incidence/epidemiology: –S. pneumo n 40-60% –S. aureus n Most without empyema n 70% in infants n 40% in adults
38
38 Parapneumonic Effusions (cont.) n Incidence/epidemiology: –S. pyogenes n Uncommon etiology of pneumonia n 55-95% have large effusion –Gram (-) n Klebsiella n E. coli n Pseudomonas
39
39 Parapneumonic Effusion Types n Complicated n Uncomplicated n Helps differentiate the need for chest tube drainage --Who cares?--
40
40 Uncomplicated Parapneumonic Effusion n pH >7.30 n Glucose >60 mg/dl n LDH of <500 IU/liter
41
41 Uncomplicated Parapneumonic Effusions n Should resolve with antimicrobial therapy for the underlying pneumonia n Suspect “complicated” if: –Temp incr. despite abx tx –Pt develops incr. Pleural fluid despite tx –Loculated effusion develops
42
42 Complicated Parapneumonic Effusion n pH <7.10 n Glucose <40 mg/dl n LDH >1,000 lU/liter)
43
Merckmedicus 200843 Complicated Parapneumonic Effusion
44
44 Complicated Parapneumonic Effusions n Should be considered for immediate drainage n Occasional patients (e.g., Streptococcus pneumoniae infections) appear to do well without drainage n No established role for repeated therapeutic thoracenteses in the treatment of complicated parapneumonic effusions.
45
45 Empyema n Drain n Antibiotics n Consider thoracotomy with decortication –Most effective for chronic empyema which does not drain completely
46
46 Malignant Pleural Effusions n Tumor involvement of the pleura or mediastinum n Malignant mesothelioma n Cytology is positive in approximately 60% of malignant effusions
47
47 Malignant Pleural Effusions n Therapeutic thoracentesis n Chemotherapy and mediastinal radiation therapy n Observation
48
48 Recurrent Malignant Effusions n Repeated thoracenteses are reasonable n Complete drainage via chest tube followed by adhesive therapy –Pleurectomy or pleural abrasion n Requires thoracotomy –Chemical sclerosis
49
49 Epidemic Pleurodynia (Bornholm Disease) n Caused by Group B Coxsackievirus n Milder in children n Epigastric or lower anterior chest pain –Sudden –Severe –Frequently intermittent and/or pleuritic
50
50 Pleurodynia (cont.) n Fever, HA, sore throat, malaise n Local tenderness, hyperesthesia, muscle swelling n Myalgias
51
51 Pleurodynia (cont.) n Course: –Subsides in 2-4 days –May relapse/recur for several weeks n Complications –Orchitis –Fibrinous pleuritis –Pericarditis –Asceptic meningitis (rare)
52
52 Pleurodynia (cont.) Pleurodynia (cont.) n Diagnosis –Usually epidemic –Sporadic cases may be isolated from throat or stool n Treatment –Symptomatic n Prognosis –Good in uncomplicated cases
53
53 Pneumothorax n Closed n Open n Tension
54
Merckmedicus 200854 Pneumothorax
55
55 Spontaneous Pneumothorax n Primary –No other concurrant lung dz n Secondary –Occurs with concurrent lung dz n BPD, CF, COPD, S. aureus infection, Infarc
56
56 Pneumothorax (other) n Traumatic n Iatrogenic –Thoracentesis –Pleural Bx –Central line placement –Ventilator associated
57
57 Clinical Presentation n Chest pain n Dyspnea n Hypoxemia n Hypotension n Non-productive cough (10%) n Sudden or insidious onset
58
58 Exam n Incr. resonance n Decr. fremitous n Decr. breath sounds n Hamman’s sign (<5%) –Crackling with heartbeat n Subcutaneous emphysema (rare) n CXR –Identify visceral pleural line
59
59 X Ray n Pneumothorax n 2 -UpToDate
60
60 X Ray n Tension Pneumothorax n 2 - UpToDate
61
61 Treatment Options n Observe n Bed rest n Oxygen n Needle decompression n Tube thorocostomy –Continue 24-48 hrs after last air leak
62
62 Basis For Treatment Decision n Patient presentation n Likelihood of resolution n Likelihood of recurrence
63
63 Resolution n 3-4 weeks n 1.25% hemithorax per day
64
64 In Review n Pleural diseases typically manifested as symptomatic effusion –Transudate –Exudate –Presence of bacteria –Presence of malignant cells
65
65 Pneumothorax n Spontaneous vs. nonspontaneous n Support & observe vs. decompress
66
66 What about those cases… n 72 year old female with history of heart failure presents with DOE. Recently stopped her evening furosemide because she was “sick of going to the bathroom all night”. n 52 Year old male who presents with slowly worsening DOE, vague CP, and weight loss. Hx reveals long term occupation as auto mechanic specializing in brake work. n 19 year old male awakened with vague right chest pain, worse with inspiration. Steadily worsening throughout the day. Now severe (9/10) and short of breath.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.